Johns Hopkins University School of Medicine researchers have discovered a dual regulatory mechanism safeguarding ...

In my work as a cancer researcher, I study the underlying mechanisms of how tumors develop and resist treatment. By ...

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy.

CMRI researchers discovered that DNA repair pathways control how cancer cells die after radiotherapy. Blocking a key repair ...

Stanford Medicine researchers sifted through thousands of single nucleotide mutations in DNA to identify fewer than 400 that are functionally associated with inherited cancer risk.

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

A recent Surgeon General's report highlighted alcohol's carcinogenic effects. A Penn State professor breaks down the process.

To do so, the team damaged three components that are essential for mitochondrial function: their DNA, a pathway used to get ...